Previous Article | Next Article 
Journal of Bacteriology, May 2000, p. 2536-2543, Vol. 182, No. 9
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Peptidase E, a Peptidase Specific for N-Terminal
Aspartic Dipeptides, Is a Serine Hydrolase
Rachel A. L.
Lassy and
Charles G.
Miller*
Department of Microbiology, University of
Illinois at Urbana-Champaign, Urbana, Illinois 61801
Received 22 November 1999/Accepted 31 January 2000
 |
ABSTRACT |
Salmonella enterica serovar Typhimurium peptidase E
(PepE) is an N-terminal Asp-specific dipeptidase. PepE is not inhibited by any of the classical peptidase inhibitors, and its amino acid sequence does not place it in any of the known peptidase structural classes. A comparison of the amino acid sequence of PepE with a number
of related sequences has allowed us to define the amino acid residues
that are strongly conserved in this family. To ensure the validity of
this comparison, we have expressed one of the most distantly related
relatives (Xenopus) in Escherichia coli and
have shown that it is indeed an Asp-specific dipeptidase with properties very similar to those of serovar Typhimurium PepE. The
sequence comparison suggests that PepE is a serine hydrolase. We have
used site-directed mutagenesis to change all of the conserved Ser, His,
and Asp residues and have found that Ser120, His157, and Asp135 are all
required for activity. Conversion of Ser120 to Cys leads to severely
reduced (104-fold) but still detectable activity, and this
activity but not that of the parent is inhibited by thiol reagents;
these results confirm that this residue is likely to be the catalytic
nucleophile. These results suggest that PepE is the prototype of a new
family of serine peptidases. The phylogenetic distribution of the
family is unusual, since representatives are found in eubacteria, an insect (Drosophila), and a vertebrate (Xenopus)
but not in the Archaea or in any of the other eukaryotes
for which genome sequences are available.
 |
INTRODUCTION |
Peptide-hydrolyzing enzymes are
required for the complete degradation of proteins to free amino acids
and for the utilization of peptides as nutrient sources.
Salmonella enterica serovar Typhimurium contains at least 14 peptidases with various substrate specificities, ensuring that these
two processes are carried out fully (12). Four of these
peptidases (peptidases N, A, B, and D) have a broad substrate
specificity, and previous studies have shown that a mutant lacking all
four enzymes is unable to completely degrade intracellular proteins to
free amino acids (19). These broad-specificity peptidases do
not, however, hydrolyze all peptides equally well. For example, none of
the four can hydrolyze X-Pro peptides (where X can be any amino acid).
Specialized enzymes (peptidases P and Q) that specifically hydrolyze
X-Pro peptides have evolved to carry out this function (11).
Only one of the broad-specificity enzymes, peptidase B, is able to
hydrolyze Asp-X peptides (Z. Mathew, T. M. Knox, and C. G. Miller, submitted for publication), and cells contain an additional
enzyme, peptidase E, that is specific for Asp-X dipeptides
(5).
Peptidase E was first identified as an activity capable of hydrolyzing
Asp-X peptides and was subsequently shown to have specificity for
aspartyl dipeptides (5). It does not hydrolyze Glu-X, Asn-X, Gly-X, or any other nonaspartyl peptide that has been tested
(5). Peptidase E requires a free N terminus and does not
cleave N-blocked peptides. The only other Asp-X-specific peptidases are
the caspases, which are endoproteases that hydrolyze an internal Asp-X
peptide bond (8, 16). The aspartyl dipeptide specificity of
peptidase E is therefore unique among characterized peptidases.
Little is known about the mechanism of action of peptidase E or about
the structural basis for its specificity. Peptidase E is not sensitive
to inhibitors of the major classes of peptidases (6), and
its sequence does not clearly place it in any known class of enzymes
(13). No structural motifs that could identify peptidase E
as a member of a known family have been recognized. Peptidase E, unlike
many Salmonella peptidases, lacks any apparent metal binding
sites that would classify it as a metalloprotease. These observations
suggest that peptidase E may define a new class of peptide hydrolases.
As sequences from other organisms have become available, peptidase E
homologs have been identified. Alignment of these sequences has
revealed several highly conserved regions, one of which contains a
Gly-X-Ser-X-Gly motif typical of serine hydrolases, suggesting that
peptidase E may utilize a serine residue as a nucleophile. The results
of site-directed mutagenesis experiments aimed at testing the
hypothesis that peptidase E is a serine peptidase and at identifying
the amino acid residues required for catalysis are presented.
 |
MATERIALS AND METHODS |
Bacterial strains and growth conditions.
All
Salmonella serovar Typhimurium strains listed in Table
1 are derivatives of strain LT2.
Escherichia coli DH5
was routinely used for DNA cloning
experiments, with the exception of site-directed mutagenesis (described
below), in which BMH71-18 mutS was used (Clontech). Strains
were typically grown at 37°C in Lennox broth (L broth) (Gibco BRL).
To supplement auxotrophy, leucine and proline were added at 0.3 and 2.0 mM, respectively. When peptides were used as leucine sources, strains
were grown on E minimal medium (17) supplemented with 0.4%
glucose and 0.3 mM peptide. For the growth of plasmid-containing
strains, ampicillin was added to the medium at 50 µg/ml.
Analysis of sequence data.
Searches for sequences similar to
the peptidase E sequence were carried out with the BLAST program
(1) to search the GenBank database maintained by the
National Center for Biotechnology Information. In addition to the
nonredundant GenBank database, the dbest database (expressed sequence
tag database) and the unfinished microbial genome database were also
searched. Drosophila melanogaster peptidase E was found in
dbest. Several sequences were found in the unfinished microbial genome
database and were accessed from the contributing sites as follows:
Deinococcus radiodurans and Shewanella
putrefaciens from The Institute for Genomic Research;
Pasteurella multocida from the University of Minnesota
Computational Biology Center; and Actinobacillus
actinomycetemcomitans from the University of Oklahoma Advanced
Center for Genome Technology. Sequence alignments were constructed with
the ClustalW algorithm.
Available GenBank accession numbers for peptidase E sequences are as
follows:
S. enterica serovar Typhimurium,
P36936;
E. coli,
P32666;
Haemophilus influenzae,
P44766;
Xenopus laevis, AAC59869; and
D. melanogaster,
AA536396 and
AI260864.
DNA manipulations.
DNA manipulations were performed by
standard techniques (10). DNA fragments were prepared for
cloning by agarose gel extraction with a Qiaquick gel extraction kit
(Qiagen). Restriction enzymes were either from Gibco BRL or from New
England Biolabs. Taq polymerase and T4 DNA ligase were from
Gibco BRL, and shrimp alkaline phosphatase was from Amersham Pharmacia
Biotech. DNA sequencing was carried out on a Perkin-Elmer ABI 377A
automated DNA sequencer at the W. M. Keck Center for Comparative
and Functional Genomics at the University of Illinois.
Plasmids were transferred between serovar Typhimurium strains with the
generalized transducing phage P22 HT 12/4
int-3
(
15).
Site-directed mutagenesis.
Oligonucleotide-directed
mutagenesis was performed essentially as described for the Transformer
Site-Directed Mutagenesis Kit (Clontech). The selection primer,
PstI/XhoI, was used with each of the mutagenic
primers, all of which are listed in Table 2. A pepE plasmid, pCM247
[pBluescript II KS(+) with a 2.6-kb serovar Typhimurium genomic DNA
insert containing pepE and two adjacent genes], was used as
the template (6). Mutated plasmids were screened for loss of
a PstI site and gain of an XhoI site by
corresponding restriction endonuclease digestion. Plasmids that were
found to have acquired an XhoI site were then screened for
pepE mutations by DNA sequencing. In the course of these
experiments, we found that strains carrying pCM247 are not stable upon
repeated subculturing. Each pepE mutant was therefore
amplified by PCR with primers PepE5 and PepE6 (Table 2) and cloned into
EcoRI/BamHI-digested pSE380 to produce plasmids
in which pepE transcription is controlled by an
isopropyl-
-D-thiogalactopyranoside (IPTG)-inducible
promoter. The presence of each mutation in the subclones was confirmed
by DNA sequencing. Wild-type peptidase E and mutant peptidase E
expressed from these pSE380 constructs were found to be completely
stable, and strains containing these plasmids (Table 2) were analyzed for peptidase E activity. The instability of pCM247-derived plasmids presumably results from the overexpression of one of the genes adjacent
to the peptidase E gene on pCM247 and not from the overexpression of
peptidase E itself. Plasmids were electroporated into TN2540 and
finally transduced into TN2719 for phenotypic analysis. The expression
of peptidase E mutants was induced by growing each plasmid-containing
strain overnight in L broth-ampicillin plus 1 mM IPTG. Soluble cell
extracts of each were prepared by sonication and subsequent
centrifugation. Activity was determined by measuring the rate of
aspartyl p-nitroanilide (Asp-pNA) (Bachem) hydrolysis as
described below.
Cloning of X. laevis pepE and Bacillus subtilis
ygaJ.
A cDNA clone of gene D2, the X. laevis pepE gene,
carried on pBluescript was kindly provided by D. Brown (18).
With restriction enzymes EcoRI and XhoI, an
800-bp fragment including the pepE open reading frame was
excised and cloned into the EcoRI/XhoI sites of
vector pSE380. The resulting plasmid, pCM441, was then electroporated
into serovar Typhimurium strain TN2540, from which it was transduced
into TN2719 and TN2718 to make TN5416 and TN5415, respectively.
B. subtilis gene
ygaJ was amplified by PCR from
strain DB104 (kindly provided by R. Switzer) with primers BsPepE1 and
BsPepE2
(Table
2). The 750-bp product was cloned into the
EcoRI/
BamHI
sites of pSE380 to produce pCM440,
which was then electroporated
into TN2540 and transduced into TN2719
and TN2718. Each of the
two resulting plasmids, pCM441 and pCM440, was
sequenced with
primer pSE380 (Table
2) and confirmed to carry the
correct
sequence.
Strain TN2718 carrying either pCM441 or pCM440 was used to determine
whether or not expression from the plasmid would allow
growth on
peptides. Cells were spread on E minimal medium containing
0.4%
glucose, 2 mM proline, and 1 mM IPTG. Crystals of either
leucine or the
following leucine-containing peptides were added
to the surface of the
medium to supplement the leucine auxotrophy:
Asp-Leu, Glu-Leu, Lys-Leu,
Tyr-Leu, Thr-Leu, and Asn-Leu.
Purification of serovar Typhimurium peptidase E.
Strain
TN5213 was grown overnight in L broth supplemented with 50 µg of
ampicillin per ml and 1 mM IPTG. Cells were harvested, washed with 0.1 M Tris-Cl (pH 7.5), and disrupted by sonication. The soluble fraction
was subjected to anion-exchange chromatography on a Q Sepharose HiLoad
26/10 column at a flow rate of 4 ml/min and eluted with a linear
gradient of 0 to 1.0 M NaCl in 20 mM Tris-Cl (pH 7.5) (in a total
volume of 1,000 ml). Asp-Leu-hydrolyzing activity, which eluted at 0.2 M NaCl, was detected by the amino acid oxidase assay (5).
Fractions containing this activity were pooled and concentrated with
Centriprep 10 concentrator units (Amicon). After equilibration in 20 mM
Tris-Cl (pH 7.5)-150 mM NaCl, the sample was subjected to gel
filtration chromatography in the same buffer with a Superose 12 HR
10/30 column at a flow rate of 0.5 ml/min. Peptidase E eluted at a
molecular mass of 25 kDa and was concentrated and desalted before
chromatography on a DEAE-Sepharose Fast Flow 10/10 column at 2 ml/min.
A linear gradient of 0 to 1.0 M NaCl in 20 mM Tris-Cl (pH 7.5) (total
volume, 200 ml) was used for elution, and the active fractions were
pooled, concentrated, and equilibrated in the gel filtration buffer.
Material from the DEAE-Sepharose step was subjected to an additional
gel filtration chromatography step on a Superose 12 HR 10/30 column at
a flow rate of 0.5 ml/min and eluted with 20 mM Tris-Cl (pH 7.5)-150
mM NaCl.
All chromatography analyses were performed on a fast protein liquid
chromatography system (Amersham Pharmacia Biotech). Protein
concentrations were determined by the Coomassie dye binding assay
with
Coomassie Plus protein reagent (Pierce) and bovine serum
albumin as the
standard.
Purification of X. laevis peptidase E.
X.
laevis peptidase E was purified from strain TN5416 essentially as
described for serovar Typhimurium peptidase E but without the final gel
filtration step. Asp-Leu-hydrolyzing activity eluted at approximately
0.1 M NaCl from the Q Sepharose column, at a predicted molecular mass
of 40 kDa from the Superose 12 column, and at 0.08 M NaCl from the
DEAE-Sepharose column.
SDS-PAGE.
Sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE) was performed as described by Schaggar and von
Jagow (14), typically with 10% separating and 4% stacking
gels. Molecular weight standards were Mark 12 wide-range protein
standards (Novex).
Assays of peptidase E activity.
Peptidase E activity was
measured by determining the rate of Asp-pNA hydrolysis (6).
The reaction mixture contained either purified enzyme or crude cell
extract in 0.1 M Tris-Cl (pH 7.5) and 1 mM Asp-pNA (from a 50 mM stock
solution in dimethylformamide). The rate of p-nitroaniline
release was measured as an increase in the A410
on a Thermomax microplate reader (Molecular Devices) at room
temperature for 30 min. When assays were done with protease inhibitors,
enzyme and inhibitor were allowed to incubate for 15 min prior to the
addition of substrate. The following inhibitors, which were obtained
from Sigma, were used: 3,4-dichloroisocoumarin, L-trans-epoxysuccinyl-leucylamide-(4-guanido)-butane
(E-64), and N-ethylmaleimide (NEM).
Hydrolysis of other peptides was carried out at 37°C with 0.1 mM
Tris-Cl (pH 7.5), 1 mM substrate (or substrate concentrations
of 0.02 to 1.0 mM and 0.06 to 1.0 mM for
Km
determinations of
the
X. laevis and
S. typhimurium enzymes, respectively), and either
30 ng of purified
serovar Typhimurium peptidase E or 400 ng of
purified
X. laevis peptidase E. Aliquots were removed from the
reaction
mixture and precipitated in 5% trichloroacetic acid (50-µl
aliquot
added to 5 µl of 50% trichloroacetic acid). Each supernatant
was
then derivatized as described by Carter (
4) with
2,4,6-trinitrobenzenesulfonic
acid (TNBS) (Pierce). Briefly, 20 µl of
the reaction mixture was
combined with 80 µl of 5% borax (1 g of
sodium borate in 20 ml
of 0.1 N KOH) and 0.25 mM isoleucine as the
internal standard
for chromatography. To derivatize the peptide and
amino acids,
4 µl of TNBS (0.05% in H
2O) was added,
mixed well, and incubated
for 5 min at room temperature. To stop the
reaction by acidification,
5 µl of 6 N HCl was added to each tube and
mixed well. The mixture
was then diluted to a 1-ml final volume by
adding 891 µl of a
solution containing 95% of 0.1% trifluoroacidic
acid (TFA) (Pierce)
in H
2O and 5% of 0.1% TFA in
acetonitrile (Fisher). The resulting
trinitrophenyl derivatives were
analyzed by reversed-phase high-pressure
liquid chromatography with a
C
18 Ultrasphere column (Beckman Instruments).
The buffers
used for chromatography were 0.1% TFA in H
2O as the
starting buffer and a 0 to 100% gradient of 0.1% TFA in acetonitrile
for
elution.
Western blot analysis.
Plasmid-containing strains were grown
overnight in L broth containing 50 µg of ampicillin per ml and 1 mM
IPTG. An aliquot of cells was then combined with 2× sample loading
buffer (0.125 M Tris-Cl [pH 6.8], 4% SDS, 20% glycerol, 0.2 M
dithiothreitol, 0.02% bromophenol blue) and heated to 100°C for 5 min before being subjected to Tris-Tricine-SDS-PAGE. Protein was
transferred from the gel to polyvinylidene difluoride by semidry
electroblotting (Hoefer), and blots were incubated sequentially in 3%
bovine serum albumin, rabbit serum containing anti-peptidase E antibody
at a 1/1,000 dilution, and anti-rabbit immunoglobulin G-alkaline phosphatase conjugate (Sigma) at a 1/1,000 dilution. Alkaline phosphatase activity was detected with Western Blue reagent (Promega). Rabbit anti-peptidase E antibody was raised against purified serovar Typhimurium peptidase E at the University of Illinois Immunological Resource Center.
 |
RESULTS |
Comparison of serovar Typhimurium peptidase E to homologs from
other organisms.
Figure 1 shows an
alignment of sequences similar to serovar Typhimurium peptidase E. The
organisms from which these sequences are derived and their percent
identity and percent similarity (in parentheses) to serovar Typhimurium
peptidase E are as follows: E. coli (89 and 92), H. influenzae (46 and 63), A. actinomycetemcomitans (42 and 59), S. putrefaciens (39 and 59), partial sequence
from P. multocida (44 and 59), X. laevis (42 and 55), and D. melanogaster (43 and 60).

View larger version (90K):
[in this window]
[in a new window]
|
FIG. 1.
Multiple alignment of the amino acid sequences of the
peptidase E family. The sequence alignment was determined with
ClustalW, and Boxshade 3.1 was used to shade positions at which 70% of
the sequences are identical (black) or similar (gray). The residues
that are essential for enzyme activity (Ser120, Asp135, His157, Arg171,
and Arg174) are indicated with asterisks. Blocks of conserved residues
are labeled with roman numerals for clarity when mentioned in the text.
Abbreviations are as follows: S.t., S. enterica serovar
Typhimurium; E.c., E. coli; A.a., A. actinomycetemcomitans; P.m., partial sequence from P. multocida; H.i., H. influenzae; S.p., S. putrefaciens; X.l., X. laevis; and D.m., D. melanogaster.
|
|
A Blast search also found two more distantly related sequences, one
from
B. subtilis (37% identity and 48% similarity) and
one
from
Deinococcus radiodurans (32% identity and 50%
similarity).
A plasmid expressing the
B. subtilis pepE
homolog (
ygaJ), pCM440,
was constructed, and its gene
product was assayed for peptide-hydrolyzing
activity. No in vitro
hydrolysis of Asp-pNA was observed. In addition,
this strain was no
better than the parent strain in its ability
to grow on X-Leu peptides
(Asp-Leu, Glu-Leu, Lys-Leu, Tyr-Leu,
Thr-Leu, and Asn-Leu) as sources
of leucine. The
B. subtilis gene
product is not similar to
the other peptidase E sequences in the
C-terminal region, which
contains two arginine residues that are
essential for catalysis, as
discussed below. Based on these observations,
the
B. subtilis
ygaJ gene product sequence and the sequence from
D. radiodurans, which is even less similar to serovar Typhimurium
peptidase E, were not included in the alignment. Although the
sequence
from
S. putrefaciens is 39% identical to that of serovar
Typhimurium peptidase E, which is not significantly more similar
than
the
B. subtilis homolog, it contains most of the strongly
conserved residues, including the two essential arginines, and
was
therefore included in the
alignment.
From the sequence alignment shown in Fig.
1, it is apparent that all
the members of the peptidase E family are approximately
the same size
and that none of them has N- or C-terminal extensions
or lengthy
divergent regions. There are at least seven conserved
blocks of
sequence, the first being a leucine-rich block at the
N terminus
(region I). Inspection of the conserved blocks led
to the
identification of a potential serine protease motif, Gly-X-Ser-X-Gly,
in region IV. Hypothesizing that peptidase E may therefore be
a serine
protease, we also identified conserved blocks containing
an aspartate
(region V) and a histidine (region VI) which, together
with serine,
could comprise a catalytic triad typical of serine
proteases.
Analysis of purified X. laevis peptidase E.
In
order to verify that the alignment in Fig. 1 includes sequences for
enzymes with similar activities, we chose one of the proteins most
distantly related to serovar Typhimurium peptidase E, that of X. laevis, for further characterization. The putative X. laevis
pepE gene (called gene D in reference 3) was
cloned into cloning vector pSE380 under the control of an inducible
promoter (ptrc) and expressed in a multiply peptidase-deficient serovar Typhimurium strain (TN5415). The enzyme was purified from extracts of
this strain (Fig. 2 and Table
3), and its activity and substrate specificity were compared to those of purified serovar Typhimurium peptidase E. As shown in Table 4, both
serovar Typhimurium peptidase E and X. laevis peptidase E
hydrolyze several aspartyl dipeptides, including Asp-Pro. Both enzymes
also hydrolyze the chromogenic substrate Asp-pNA. In addition, both
hydrolyze the tripeptide Asp-Gly-Gly at approximately 50% the rate for
Asp-Leu. Asp-Gly-Gly is the smallest aspartyl tripeptide, which may
explain why this peptide is a substrate for peptidase E, whereas other
tripeptides are not. No significant activity was detected toward any
larger tripeptides, such as Asp-Leu-Gly. In addition, no hydrolysis of any non-aspartyl peptides was observed for either serovar Typhimurium or X. laevis peptidase E. The apparent Michaelis constant
for each enzyme toward Asp-Leu was determined to be approximately 0.3 mM. However, the kcat/Km of serovar
Typhimurium peptidase E for Asp-Leu (2.08 × 103
M
1 s
1) is 10-fold higher than that of the
X. laevis enzyme (0.24 × 103
M
1 s
1). These results indicate that
X. laevis peptidase E is a strict Asp-X peptidase with a
specificity very similar to that of serovar Typhimurium peptidase E.

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 2.
Peptidase E purification. (A) X. laevis
peptidase E was purified from soluble cell extracts of strain TN5415 as
described in Materials and Methods. Samples from each step in the
purification were analyzed by SDS-PAGE and loaded as follows: crude
cell extract (lane 1), pooled Q Sepharose fractions (lane 2), pooled
Superose fractions (lane 3), and pooled DEAE fractions (lane 4). (B)
Serovar Typhimurium peptidase E, which was purified as described in
Materials and Methods, was subjected to SDS-PAGE and loaded in lane 5. Molecular mass markers were loaded in lanes labeled "M," and their
masses (in kilodaltons) are noted to the left of the gels. The band on
each gel corresponding to peptidase E is indicated with an arrow.
|
|
Although the activities of peptidase E from these two different
organisms are very similar, the surface-exposed residues must
be quite
different. Cross-reactivity of polyclonal antibody raised
against
serovar Typhimurium peptidase E was barely detectable
toward
X. laevis peptidase E, as determined by Western blotting
(data not
shown).
Site-directed mutagenesis of potential active-site of peptidase
E.
Site-directed mutagenesis was used to change each of the
conserved serine (Ser7, Ser9, and Ser120), histidine (His19,
His68, His157, and His166), and aspartate (Asp47 and
Asp135) residues of serovar Typhimurium peptidase E individually
to alanine, and the effects of these mutations on enzyme activity
were assayed by measuring the rate of Asp-pNA hydrolysis. The
results (Fig. 3) clearly show that
although all of these residues are conserved, not all are
required for enzyme activity. Of the three conserved serine residues, a
mutation in only one, Ser120, abolished activity, indicating that
neither Ser7 nor Ser9 can be the catalytic nucleophile.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Asp-pNA-hydrolyzing activity of peptidase E
site-directed mutants compared to that of the wild type,
Salmonella strain TN2719 (leuBCD485
pepE8::MudJ) carrying plasmid pSE380 (vector [V]),
wild-type peptidase E plasmid (pCM389) (WT), or mutant peptidase E
plasmids (listed in Table 2) was grown overnight in L broth containing
50 µg of ampicillin per ml and 1 mM IPTG. Soluble cell extracts of
each strain were assayed for Asp-pNA-hydrolyzing activity as described
in Materials and Methods. Error bars show standard deviations.
|
|
For some serine hydrolases it has been shown that replacement of the
active-site serine by cysteine leads to an enzyme with
greatly reduced
but still detectable activity (
7). To further
investigate
the role of Ser120 in peptidase E catalysis, a mutant
with a Ser120Cys
substitution was constructed, and its ability
to hydrolyze Asp-pNA was
tested. The Ser120Cys mutant hydrolyzed
Asp-pNA at a
10
4-fold lower rate than the wild type, as measured from
crude cell
extracts of plasmid-containing strains (TN2719/pCM389
and TN2719/pCM456).
The sensitivity of a purified preparation of the
Ser120Cys mutant
to cysteine protease inhibitors was compared to that
of the wild-type
enzyme (Table
5). The
Ser120Cys mutant was expected to have the
characteristics of a cysteine
protease, including sensitivity
to compounds which specifically inhibit
cysteine proteases. Wild-type
peptidase E was not affected by
iodoacetate, NEM, or E-64, but
the activity of the Ser120Cys mutant was
significantly decreased
by all three inhibitors. This result indicates
that the cysteine
residue in this mutant is important for
catalysis and that it
potentially acts as the nucleophile. The results
of these experiments,
together with the results for the Ser120Ala
mutant, provide strong
evidence that peptidase E is a serine peptidase
and that Ser120
is the active-site nucleophile.
Mutation in one of the two conserved aspartate residues led to the loss
of enzymatic activity, indicating that only Asp135
is required for
activity. Two of the conserved histidine residues
(His68 and His166)
could be changed to alanine without a loss
of activity. Conversion of
either His19 or His157 to alanine,
however, led to a complete loss of
enzymatic activity. To further
investigate the role of the histidine
residues, each of the four
histidine residues was changed to glutamine,
a more conservative
change than a mutation to alanine. The His157Gln
mutation resulted
in an inactive enzyme, whereas His19Gln led to an
active enzyme,
indicating that His157 is the only one of the four
conserved histidine
residues required for
activity.
To determine whether or not the mutations affected activity directly or
simply caused protein instability, the presence of
peptidase E protein
in cell extracts of each inactive mutant was
detected by Western
blotting with polyclonal antibody raised to
wild-type serovar
Typhimurium peptidase E. The results (Fig.
4)
indicate that most of the mutations do
not affect the stability
of peptidase E. Both Ser120Cys and His166Gln
mutants are present
in significantly smaller amounts than the wild
type. However,
the Ser120Cys mutant can be purified, has measurable
activity,
and so is presumed to be stable, and another mutation at
His166
(His166Ala) did not abolish activity, suggesting that this
residue
is not essential. The conclusion, therefore, is that the
mutations
that led to inactivity affected enzyme activity rather than
enzyme
stability.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Western blot analysis of peptidase E mutants. Extracts
of strains overexpressing wild-type (from pCM389) or mutant (from
plasmids listed in Table 2) peptidase E were analyzed by SDS-PAGE and
Western blotting as described in Materials and Methods.
|
|
Analysis of potential substrate specificity mutations.
Because
peptidase E recognizes negatively charged substrates (aspartyl
peptides), it was hypothesized that positively charged residues may be
required in the active site to interact with the P1 aspartate of the
substrate. Site-directed mutagenesis was used to change each of the
conserved positively charged amino acids to either alanine or
glutamate. In the initial sequence alignment, Lys95 appeared to be
conserved, so a Lys95Ala mutant was constructed and found to retain
Asp-pNA hydrolytic activity. Two sequences that were recently added to
the peptidase E family (from S. putrefaciens and D. melanogaster) do not have a conserved lysine at the position equivalent to Lys95, confirming that this residue is not essential. Two
arginine residues located in region VII, Arg171 and Arg174, are
completely conserved. Mutations were constructed in each residue, Arg171Glu, Arg174Ala, and Arg174Glu; all led to an inactive enzyme (Fig. 3). In addition, none of the arginine mutants appeared to acquire
new activity toward non-aspartyl peptides. A mutation in a conserved
glutamate, Glu172Ala, had little effect on peptidase E activity, even
though it is in close proximity to the two conserved arginine residues.
We conclude that Arg171 and Arg174 are essential for peptidase E
activity, but we have not shown that either is responsible for Asp-X
peptide specificity.
 |
DISCUSSION |
The results presented here define a new family of peptidases, the
first member of which was peptidase E from serovar Typhimurium. An
analysis of the catalytic residues of this family was based on a
sequence comparison of all known peptidase E homologs which, at the
start of this work, included only those from serovar Typhimurium, E. coli, H. influenzae, and X. laevis.
Peptidase E from X. laevis was especially useful in the
sequence alignment because, with this distantly related homolog, we
were able to derive a meaningful consensus sequence for the family. The
X. laevis pepE gene, called gene D, was one of 39 genes
found to be up-regulated by thyroid hormone during the late stages of
tail resorption in tadpoles (18). X. laevis
peptidase E was purified, and its specificity was shown to be nearly
identical to that of serovar Typhimurium peptidase E. The similarity in
substrate specificity of these two enzymes in combination with the high
degree of sequence conservation among all members of the family led to
the conclusion that members of the peptidase E family not only are
structurally related but also share an unusual strict specificity for
small aspartyl peptides. The defining characteristics of the family,
which now contains eight members from different organisms, are as
follows: specificity for small aspartyl peptides, including dipeptides
and Asp-Gly-Gly; a requirement for a free N-terminal aspartate; a
molecular mass of approximately 25 kDa; and a catalytic serine.
There may be a broader peptidase E family including the product of the
B. subtilis ygaJ gene, which has sequence similarity to
peptidase E; however, ygaJ does not encode an
aspartyl-specific peptidase. It is common for families of proteases to
share structural features but to differ in substrate specificities;
therefore, the gene products from both B. subtilis (37%
identity) and D. radiodurans (32% identity) may be included
in a family of proteins with the structural characteristics of
peptidase E.
An alignment of the eight most similar sequences presumed to share
substrate specificity was used to identify residues within conserved
regions thought to be important for catalysis. Site-directed mutagenesis suggests that peptidase E is a serine protease that utilizes a catalytic triad of Ser120, Asp135, and His157. The recently
solved crystal structure of serovar Typhimurium peptidase E confirms
that Ser120 and His157 have the correct proximity and orientation for
catalysis (K. Håkansson, A. Wang, and C. G. Miller, unpublished
results). The distance of Asp135 from His157, however, suggests that
Asp135 is not part of the catalytic triad. Because this residue is
essential, it must still play an important role in peptidase E activity.
The proposal that Ser120 is the active-site nucleophile is supported by
its location in a typical serine hydrolase motif (Gly-X-Ser-X-Gly) and
by the importance of this residue for peptidase E activity. This
proposal is also supported by the fact that substitution of Cys for
Ser120 leads to a protein with low but detectable enzymatic activity
and that this activity, but not that of the wild type, is inhibited by
thiol reagents. Similar results have been found for other serine
hydrolases, such as rat trypsin, in which a Ser195Cys mutant has
different levels of activity depending upon the substrate tested,
ranging from no detectable activity to activity 30-fold lower than that
of the wild type (7). The serine hydrolase Tsp protease
(tail-specific protease encoded by prc in E. coli) is also tolerant to a change from serine (Ser430) to
cysteine, the Ser430Cys mutant having 5 to 10% wild-type activity
(9). In addition, Ser-to-Cys mutants of both trypsin and Tsp
protease are sensitive to Cys protease inhibitors, like the peptidase E Ser120Cys mutant.
The phylogenetic distribution of members of the peptidase E family is
unusual. Peptidase E is present in the
-proteobacteria but is also
present in two eukaryotes. Although peptidase E from D. melanogaster has not been tested experimentally for aspartyl dipeptidase activity, the amino acid residues shown to be important for
peptidase E activity are all conserved, implying that D. melanogaster peptidase E has the same activity as the others.
Interestingly, neither of the two eukaryotes for which the complete
genome sequences are available, Caenorhabditis elegans and
Saccharomyces cerevisiae, has a peptidase E homolog. In
addition, no homologs were found in any of the archaeal genomes that
have been completely sequenced, including Methanococcus
jannaschii, Methanobacterium thermoautotrophicum, Archaeoglobus fulgidus, Pyrococcus horikoshii,
and Aeropyrum pernix. These observations indicate that
peptidase E has a wide but sporadic phylogenetic distribution, being
present in eubacteria, an insect, and an amphibian but not in other
eukaryotes or in archaea.
Other peptidases, such as the broad-specificity aminopeptidases
peptidase N, peptidase B, and peptidase A and the proline-specific peptidase peptidase P, are found in a wide variety of organisms representing all three domains of the phylogenetic tree. The fact that
peptidase E is not so widespread leads to the speculation that it plays
a more specialized role in organisms in which it is found. For example,
in X. laevis, peptidase E is induced during a particular
late stage of development, suggesting a function for this enzyme beyond
that of generalized peptide hydrolysis. It will be interesting to learn
the role of peptidase E in different organisms and to further analyze
the distribution of new members of the peptidase E family as genome
sequences become available.
 |
ACKNOWLEDGMENTS |
This work was supported by a grant (AI10333) from the National
Institute of Allergy and Infectious Diseases. R.A.L.L. was supported in
part by a training grant (5 T32 GMO7283) from the National Institute of
General Medical Sciences.
We thank Kjell Håkansson for providing purified Ser120Cys peptidase E
and for sharing unpublished results about the peptidase E crystal
structure. We acknowledge the contributions of Lhing-Yew Li to this
project. We thank Donald Brown for provided a cDNA clone encoding
the X. laevis enzyme and Robert Switzer for providing B. subtilis.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, University of Illinois at Urbana-Champaign, B103 CLSL, 601 S. Goodwin Ave., Urbana, IL 61801. Phone: (217) 244-8418. Fax:
(217) 244-6697. E-mail: charlesm{at}life.uiuc.edu.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Brosius, J.
1989.
Superpolylinkers in cloning and expression vectors.
DNA
8:759-777[Medline].
|
| 3.
|
Brown, D. D.,
Z. Wang,
J. D. Furlow,
A. Kanamori,
R. A. Schwartzman,
B. F. Remo, and A. Pinder.
1996.
The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis.
Proc. Natl. Acad. Sci. USA
93:1924-1929[Abstract/Free Full Text].
|
| 4.
|
Carter, T. H.
1982.
Ph.D. thesis.
Case Western Reserve University, Cleveland, Ohio.
|
| 5.
|
Carter, T. H., and C. G. Miller.
1984.
Aspartate-specific peptidases in Salmonella typhimurium: mutants deficient in peptidase E.
J. Bacteriol.
159:453-459[Abstract/Free Full Text].
|
| 6.
|
Conlin, C. A.,
K. Håkansson,
A. Liljas, and C. G. Miller.
1994.
Cloning and nucleotide sequence of the cyclic AMP receptor protein-regulated Salmonella typhimurium pepE gene and crystallization of its product, an -aspartyl dipeptidase.
J. Bacteriol.
176:166-172[Abstract/Free Full Text].
|
| 7.
|
Higaki, J. N.,
L. B. Evnin, and C. S. Craik.
1989.
Introduction of a cysteine protease active site into trypsin.
Biochemistry
28:9256-9263[CrossRef][Medline].
|
| 8.
|
Howard, A. D.,
M. J. Kostura,
N. Thornberry,
G. J. Ding,
G. Limjuco,
J. Weidner,
J. P. Salley,
K. A. Hogquist,
D. D. Chaplin,
R. A. Mumford,
J. A. Schmidt, and M. J. Tocci.
1991.
IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.
J. Immunol.
147:2964-2969[Abstract].
|
| 9.
|
Keiler, K. C., and R. T. Sauer.
1995.
Identification of active site residues of the Tsp protease.
J. Biol. Chem.
270:28864-28868[Abstract/Free Full Text].
|
| 10.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 11.
|
McHugh, G. L., and C. G. Miller.
1974.
Isolation and characterization of proline peptidase mutants of Salmonella typhimurium.
J. Bacteriol.
120:364-371[Abstract/Free Full Text].
|
| 12.
|
Miller, C. G.
1996.
Protein degradation and proteolytic modification, p. 938-954.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. American Society for Microbiology, Washington, D.C.
|
| 13.
|
Rawlings, N. D., and A. J. Barrett.
1993.
Evolutionary families of peptidases.
Biochem. J.
290:205-218.
|
| 14.
|
Schagger, H., and G. von Jagow.
1987.
Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for separation of proteins in the range from 1 to 100 kDa.
Anal. Biochem.
166:368-379[CrossRef][Medline].
|
| 15.
|
Schmieger, H.
1972.
Phage P22 mutants with increased or decreased transduction abilities.
Mol. Gen. Genet.
119:75-88[CrossRef][Medline].
|
| 16.
|
Sleath, P. R.,
R. C. Hendrickson,
S. R. Kronheim,
C. J. March, and R. A. Black.
1990.
Substrate specificity of the protease that processes human interleukin-1 beta.
J. Biol. Chem.
265:14526-14528[Abstract/Free Full Text].
|
| 17.
|
Vogel, H. J., and D. M. Bonner.
1956.
Acetylornithinase of Escherichia coli: partial purification and some properties.
J. Biol. Chem.
218:97-106[Free Full Text].
|
| 18.
|
Wang, Z., and D. D. Brown.
1993.
Thyroid hormone-induced gene expression program for amphibian tail resorption.
J. Biol. Chem.
268:16270-16278[Abstract/Free Full Text].
|
| 19.
|
Yen, C.,
L. Green, and C. G. Miller.
1980.
Peptide accumulation during growth of peptidase deficient mutants.
J. Mol. Biol.
143:35-48[CrossRef][Medline].
|
Journal of Bacteriology, May 2000, p. 2536-2543, Vol. 182, No. 9
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Waterhouse, J. C., Russell, R. R. B.
(2006). Dispensable genes and foreign DNA in Streptococcus mutans. Microbiology
152: 1777-1788
[Abstract]
[Full Text]
-
Klomklang, W., Tani, A., Kimbara, K., Mamoto, R., Ueda, T., Shimao, M., Kawai, F.
(2005). Biochemical and molecular characterization of a periplasmic hydrolase for oxidized polyvinyl alcohol from Sphingomonas sp. strain 113P3. Microbiology
151: 1255-1262
[Abstract]
[Full Text]
-
Broder, D. H., Miller, C. G.
(2003). DapE Can Function as an Aspartyl Peptidase in the Presence of Mn2+. J. Bacteriol.
185: 4748-4754
[Abstract]
[Full Text]
-
Larsen, R. A., Knox, T. M., Miller, C. G.
(2001). Aspartic Peptide Hydrolases in Salmonella enterica Serovar Typhimurium. J. Bacteriol.
183: 3089-3097
[Abstract]
[Full Text]
-
Håkansson, K., Wang, A. H.-J., Miller, C. G.
(2000). The structure of aspartyl dipeptidase reveals a unique fold with a Ser-His-Glu catalytic triad. Proc. Natl. Acad. Sci. USA
10.1073/pnas.260376797v1
[Abstract]
[Full Text]
-
Hakansson, K., Wang, A. H.-J., Miller, C. G.
(2000). The structure of aspartyl dipeptidase reveals a unique fold with a Ser-His-Glu catalytic triad. Proc. Natl. Acad. Sci. USA
97: 14097-14102
[Abstract]
[Full Text]